News & Blogs

Intranasal Fentanyl: A Breath of Fresh Air in Sickle Cell Pain Management

Intranasal Fentanyl: A Breath of Fresh Air in Sickle Cell Pain Management

Author(s): Michelle Lin, MD

Introduction Sickle cell disease (SCD) and the associated vaso-occlusive episodes (VOEs) remain a significant health challenge, particularly among children. Additionally, the National Heart, Lung, and Blood Institute recommended that parenteral opioids be given within 30 minutes from triage or 60 minutes from emergency department (ED) registration. Realistically, these are challenging benchmarks to meet, partly because […]
Role of Procalcitonin Level for Serious Bacterial Illness in Febrile Infants

Role of Procalcitonin Level for Serious Bacterial Illness in Febrile Infants

Author(s): Julia Magaña, MD

Introduction Each year, U.S. emergency departments face the challenge of evaluating around 200,000 infants aged 60 days and younger, with 8-10% having serious bacterial infections, including the serious categories of bacteremia and bacterial meningitis. The PECARN febrile infant working group previously derived a clinical prediction rule to identify febrile infants at low risk for serious […]

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of the Emergency Medical Services for Children Data Center award totaling $3,200,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.

PECARN is committed to making health care information accessible for everyone. Please contact melissa.laws@hsc.utah.edu if you encounter a document, such as an older PDF brochure or historical form, that has not been optimized for your screen reader. We consider these remediation requests a top priority and will provide an accessible version as soon as possible.